FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
30,862,185
Share change
-155,541
Total reported value
$429,661,693
Put/Call ratio
67%
Price per share
$13.92
Number of holders
111
Value change
-$7,372,496
Number of buys
56
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q3 2018

As of 30 Sep 2018, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,862,185 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BVF INC/IL, BlackRock Inc., Vanguard Group Inc, GREAT POINT PARTNERS LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 111 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.